The medtech segment achieved operational revenue growth of 4.4% despite ongoing weaknesses in the Chinese market. Notably, ...

The family behind the largest pickle company in America is branching out into the cannabis industry through Vlasic Labs, even ...

Three Motley Fool contributors think they've identified dirt-cheap healthcare stocks to buy right now. Here's why they picked CRISPR Therapeutics (NASDAQ: CRSP), Gilead Sciences (NASDAQ: GILD), and ...

KResearch maintains its GDP projection for 2024 at 2.6 %, with growth in 2H24 expected to be higher than in 1H24. Attention ...

A food company affected by an allergy alert over contaminated mustard ingredients has said that no peanuts have been detected ...

It could be argued that attaining an MBA degree does help position one in the best way to succeed in entrepreneurship or the ...

From the story of McDonald's founder to a documentary about the cautionary tale of LuLaRoe, these films are essential viewing ...

Texas has seen a record number of chronic wasting disease cases this year. It is looking for new ways to contain it without ...

For two generations, American companies have been run to maximize short-term financial returns instead of to produce great ...

You do not have to look for one of the most popular Sturgeon Bay Farmer’s Market vendors on Saturday: follow your nose.

Nike ysed to rule the sportswear business. Its recent earnings have been weak. It has too much good competition.

Zimmer Biomet's struggle with market share, operational improvements, and financial performance, with potential for growth.